Severe acute respiratory syndrome (SARS): a year in review.
Identifieur interne : 002495 ( PubMed/Checkpoint ); précédent : 002494; suivant : 002496Severe acute respiratory syndrome (SARS): a year in review.
Auteurs : Danuta M. Skowronski [Canada] ; Caroline Astell ; Robert C. Brunham ; Donald E. Low ; Martin Petric ; Rachel L. Roper ; Pierre J. Talbot ; Theresa Tam ; Lorne BabiukSource :
- Annual review of medicine [ 0066-4219 ] ; 2005.
Descripteurs français
- KwdFr :
- ARN viral (génétique), Anti-inflammatoires (usage thérapeutique), Antiviraux (usage thérapeutique), Coronavirus (génétique), Diagnostic différentiel, Facteurs de risque, Flambées de maladies, Humains, Infections à coronavirus (diagnostic), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (transmission), Infections à coronavirus (épidémiologie), Pratique en santé publique, Prévention secondaire, Régulation de l'expression des gènes viraux (physiologie), Résultat thérapeutique, Syndrome respiratoire aigu sévère (diagnostic), Syndrome respiratoire aigu sévère (traitement médicamenteux), Syndrome respiratoire aigu sévère (transmission), Syndrome respiratoire aigu sévère (épidémiologie), Zoonoses.
- MESH :
- diagnostic : Infections à coronavirus, Syndrome respiratoire aigu sévère.
- génétique : ARN viral, Coronavirus.
- physiologie : Régulation de l'expression des gènes viraux.
- traitement médicamenteux : Infections à coronavirus, Syndrome respiratoire aigu sévère.
- usage thérapeutique : Anti-inflammatoires, Antiviraux, Infections à coronavirus, Syndrome respiratoire aigu sévère.
- épidémiologie : Infections à coronavirus, Syndrome respiratoire aigu sévère.
- Diagnostic différentiel, Facteurs de risque, Flambées de maladies, Humains, Pratique en santé publique, Prévention secondaire, Résultat thérapeutique, Zoonoses.
English descriptors
- KwdEn :
- Anti-Inflammatory Agents (therapeutic use), Antiviral Agents (therapeutic use), Coronavirus (genetics), Coronavirus Infections (diagnosis), Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Coronavirus Infections (transmission), Diagnosis, Differential, Disease Outbreaks, Gene Expression Regulation, Viral (physiology), Humans, Public Health Practice, RNA, Viral (genetics), Risk Factors, Secondary Prevention, Severe Acute Respiratory Syndrome (diagnosis), Severe Acute Respiratory Syndrome (drug therapy), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (transmission), Treatment Outcome, Zoonoses.
- MESH :
- chemical , genetics : RNA, Viral.
- chemical , therapeutic use : Anti-Inflammatory Agents, Antiviral Agents.
- diagnosis : Coronavirus Infections, Severe Acute Respiratory Syndrome.
- drug therapy : Coronavirus Infections, Severe Acute Respiratory Syndrome.
- epidemiology : Coronavirus Infections, Severe Acute Respiratory Syndrome.
- genetics : Coronavirus.
- physiology : Gene Expression Regulation, Viral.
- transmission : Coronavirus Infections, Severe Acute Respiratory Syndrome.
- Diagnosis, Differential, Disease Outbreaks, Humans, Public Health Practice, Risk Factors, Secondary Prevention, Treatment Outcome, Zoonoses.
Abstract
Severe acute respiratory syndrome (SARS) emerged from China as an untreatable and rapidly spreading respiratory illness of unknown etiology. Following point source exposure in February 2003, more than a dozen guests infected at a Hong Kong hotel seeded multi-country outbreaks that persisted through the spring of 2003. The World Health Organization responded by invoking traditional public health measures and advanced technologies to control the illness and contain the cause. A novel coronavirus was implicated and its entire genome was sequenced by mid-April 2003. The urgency of responding to this threat focused scientific endeavor and stimulated global collaboration. Through real-time application of accumulating knowledge, the world proved capable of arresting the first pandemic threat of the twenty-first century, despite early respiratory-borne spread and global susceptibility. This review synthesizes lessons learned from this remarkable achievement. These lessons can be applied to re-emergence of SARS or to the next pandemic threat to arise.
DOI: 10.1146/annurev.med.56.091103.134135
PubMed: 15660517
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:15660517Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Severe acute respiratory syndrome (SARS): a year in review.</title><author><name sortKey="Skowronski, Danuta M" sort="Skowronski, Danuta M" uniqKey="Skowronski D" first="Danuta M" last="Skowronski">Danuta M. Skowronski</name><affiliation wicri:level="1"><nlm:affiliation>University of British Columbia Center for Disease Control, Vancouver, British Columbia, Canada V5Z 4R4. danuta.skowronski@bccdc.ca</nlm:affiliation><country>Canada</country><wicri:regionArea>University of British Columbia Center for Disease Control, Vancouver, British Columbia</wicri:regionArea><wicri:noRegion>British Columbia</wicri:noRegion></affiliation></author><author><name sortKey="Astell, Caroline" sort="Astell, Caroline" uniqKey="Astell C" first="Caroline" last="Astell">Caroline Astell</name></author><author><name sortKey="Brunham, Robert C" sort="Brunham, Robert C" uniqKey="Brunham R" first="Robert C" last="Brunham">Robert C. Brunham</name></author><author><name sortKey="Low, Donald E" sort="Low, Donald E" uniqKey="Low D" first="Donald E" last="Low">Donald E. Low</name></author><author><name sortKey="Petric, Martin" sort="Petric, Martin" uniqKey="Petric M" first="Martin" last="Petric">Martin Petric</name></author><author><name sortKey="Roper, Rachel L" sort="Roper, Rachel L" uniqKey="Roper R" first="Rachel L" last="Roper">Rachel L. Roper</name></author><author><name sortKey="Talbot, Pierre J" sort="Talbot, Pierre J" uniqKey="Talbot P" first="Pierre J" last="Talbot">Pierre J. Talbot</name></author><author><name sortKey="Tam, Theresa" sort="Tam, Theresa" uniqKey="Tam T" first="Theresa" last="Tam">Theresa Tam</name></author><author><name sortKey="Babiuk, Lorne" sort="Babiuk, Lorne" uniqKey="Babiuk L" first="Lorne" last="Babiuk">Lorne Babiuk</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15660517</idno><idno type="pmid">15660517</idno><idno type="doi">10.1146/annurev.med.56.091103.134135</idno><idno type="wicri:Area/PubMed/Corpus">002927</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002927</idno><idno type="wicri:Area/PubMed/Curation">002927</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002927</idno><idno type="wicri:Area/PubMed/Checkpoint">002495</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002495</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Severe acute respiratory syndrome (SARS): a year in review.</title><author><name sortKey="Skowronski, Danuta M" sort="Skowronski, Danuta M" uniqKey="Skowronski D" first="Danuta M" last="Skowronski">Danuta M. Skowronski</name><affiliation wicri:level="1"><nlm:affiliation>University of British Columbia Center for Disease Control, Vancouver, British Columbia, Canada V5Z 4R4. danuta.skowronski@bccdc.ca</nlm:affiliation><country>Canada</country><wicri:regionArea>University of British Columbia Center for Disease Control, Vancouver, British Columbia</wicri:regionArea><wicri:noRegion>British Columbia</wicri:noRegion></affiliation></author><author><name sortKey="Astell, Caroline" sort="Astell, Caroline" uniqKey="Astell C" first="Caroline" last="Astell">Caroline Astell</name></author><author><name sortKey="Brunham, Robert C" sort="Brunham, Robert C" uniqKey="Brunham R" first="Robert C" last="Brunham">Robert C. Brunham</name></author><author><name sortKey="Low, Donald E" sort="Low, Donald E" uniqKey="Low D" first="Donald E" last="Low">Donald E. Low</name></author><author><name sortKey="Petric, Martin" sort="Petric, Martin" uniqKey="Petric M" first="Martin" last="Petric">Martin Petric</name></author><author><name sortKey="Roper, Rachel L" sort="Roper, Rachel L" uniqKey="Roper R" first="Rachel L" last="Roper">Rachel L. Roper</name></author><author><name sortKey="Talbot, Pierre J" sort="Talbot, Pierre J" uniqKey="Talbot P" first="Pierre J" last="Talbot">Pierre J. Talbot</name></author><author><name sortKey="Tam, Theresa" sort="Tam, Theresa" uniqKey="Tam T" first="Theresa" last="Tam">Theresa Tam</name></author><author><name sortKey="Babiuk, Lorne" sort="Babiuk, Lorne" uniqKey="Babiuk L" first="Lorne" last="Babiuk">Lorne Babiuk</name></author></analytic><series><title level="j">Annual review of medicine</title><idno type="ISSN">0066-4219</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Inflammatory Agents (therapeutic use)</term><term>Antiviral Agents (therapeutic use)</term><term>Coronavirus (genetics)</term><term>Coronavirus Infections (diagnosis)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (transmission)</term><term>Diagnosis, Differential</term><term>Disease Outbreaks</term><term>Gene Expression Regulation, Viral (physiology)</term><term>Humans</term><term>Public Health Practice</term><term>RNA, Viral (genetics)</term><term>Risk Factors</term><term>Secondary Prevention</term><term>Severe Acute Respiratory Syndrome (diagnosis)</term><term>Severe Acute Respiratory Syndrome (drug therapy)</term><term>Severe Acute Respiratory Syndrome (epidemiology)</term><term>Severe Acute Respiratory Syndrome (transmission)</term><term>Treatment Outcome</term><term>Zoonoses</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>ARN viral (génétique)</term><term>Anti-inflammatoires (usage thérapeutique)</term><term>Antiviraux (usage thérapeutique)</term><term>Coronavirus (génétique)</term><term>Diagnostic différentiel</term><term>Facteurs de risque</term><term>Flambées de maladies</term><term>Humains</term><term>Infections à coronavirus (diagnostic)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Infections à coronavirus (transmission)</term><term>Infections à coronavirus (épidémiologie)</term><term>Pratique en santé publique</term><term>Prévention secondaire</term><term>Régulation de l'expression des gènes viraux (physiologie)</term><term>Résultat thérapeutique</term><term>Syndrome respiratoire aigu sévère (diagnostic)</term><term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term><term>Syndrome respiratoire aigu sévère (transmission)</term><term>Syndrome respiratoire aigu sévère (épidémiologie)</term><term>Zoonoses</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>RNA, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Inflammatory Agents</term><term>Antiviral Agents</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à coronavirus</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Coronavirus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>ARN viral</term><term>Coronavirus</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Régulation de l'expression des gènes viraux</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Gene Expression Regulation, Viral</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anti-inflammatoires</term><term>Antiviraux</term><term>Infections à coronavirus</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Diagnosis, Differential</term><term>Disease Outbreaks</term><term>Humans</term><term>Public Health Practice</term><term>Risk Factors</term><term>Secondary Prevention</term><term>Treatment Outcome</term><term>Zoonoses</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Diagnostic différentiel</term><term>Facteurs de risque</term><term>Flambées de maladies</term><term>Humains</term><term>Pratique en santé publique</term><term>Prévention secondaire</term><term>Résultat thérapeutique</term><term>Zoonoses</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) emerged from China as an untreatable and rapidly spreading respiratory illness of unknown etiology. Following point source exposure in February 2003, more than a dozen guests infected at a Hong Kong hotel seeded multi-country outbreaks that persisted through the spring of 2003. The World Health Organization responded by invoking traditional public health measures and advanced technologies to control the illness and contain the cause. A novel coronavirus was implicated and its entire genome was sequenced by mid-April 2003. The urgency of responding to this threat focused scientific endeavor and stimulated global collaboration. Through real-time application of accumulating knowledge, the world proved capable of arresting the first pandemic threat of the twenty-first century, despite early respiratory-borne spread and global susceptibility. This review synthesizes lessons learned from this remarkable achievement. These lessons can be applied to re-emergence of SARS or to the next pandemic threat to arise.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15660517</PMID><DateCompleted><Year>2005</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0066-4219</ISSN><JournalIssue CitedMedium="Print"><Volume>56</Volume><PubDate><Year>2005</Year></PubDate></JournalIssue><Title>Annual review of medicine</Title><ISOAbbreviation>Annu. Rev. Med.</ISOAbbreviation></Journal><ArticleTitle>Severe acute respiratory syndrome (SARS): a year in review.</ArticleTitle><Pagination><MedlinePgn>357-81</MedlinePgn></Pagination><Abstract><AbstractText>Severe acute respiratory syndrome (SARS) emerged from China as an untreatable and rapidly spreading respiratory illness of unknown etiology. Following point source exposure in February 2003, more than a dozen guests infected at a Hong Kong hotel seeded multi-country outbreaks that persisted through the spring of 2003. The World Health Organization responded by invoking traditional public health measures and advanced technologies to control the illness and contain the cause. A novel coronavirus was implicated and its entire genome was sequenced by mid-April 2003. The urgency of responding to this threat focused scientific endeavor and stimulated global collaboration. Through real-time application of accumulating knowledge, the world proved capable of arresting the first pandemic threat of the twenty-first century, despite early respiratory-borne spread and global susceptibility. This review synthesizes lessons learned from this remarkable achievement. These lessons can be applied to re-emergence of SARS or to the next pandemic threat to arise.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Skowronski</LastName><ForeName>Danuta M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>University of British Columbia Center for Disease Control, Vancouver, British Columbia, Canada V5Z 4R4. danuta.skowronski@bccdc.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astell</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Brunham</LastName><ForeName>Robert C</ForeName><Initials>RC</Initials></Author><Author ValidYN="Y"><LastName>Low</LastName><ForeName>Donald E</ForeName><Initials>DE</Initials></Author><Author ValidYN="Y"><LastName>Petric</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Roper</LastName><ForeName>Rachel L</ForeName><Initials>RL</Initials></Author><Author ValidYN="Y"><LastName>Talbot</LastName><ForeName>Pierre J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Tam</LastName><ForeName>Theresa</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Babiuk</LastName><ForeName>Lorne</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Rev Med</MedlineTA><NlmUniqueID>2985151R</NlmUniqueID><ISSNLinking>0066-4219</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017934" MajorTopicYN="N">Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015967" MajorTopicYN="N">Gene Expression Regulation, Viral</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015980" MajorTopicYN="N">Public Health Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015047" MajorTopicYN="N">Zoonoses</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>102</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>1</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>7</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>1</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15660517</ArticleId><ArticleId IdType="doi">10.1146/annurev.med.56.091103.134135</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country></list><tree><noCountry><name sortKey="Astell, Caroline" sort="Astell, Caroline" uniqKey="Astell C" first="Caroline" last="Astell">Caroline Astell</name><name sortKey="Babiuk, Lorne" sort="Babiuk, Lorne" uniqKey="Babiuk L" first="Lorne" last="Babiuk">Lorne Babiuk</name><name sortKey="Brunham, Robert C" sort="Brunham, Robert C" uniqKey="Brunham R" first="Robert C" last="Brunham">Robert C. Brunham</name><name sortKey="Low, Donald E" sort="Low, Donald E" uniqKey="Low D" first="Donald E" last="Low">Donald E. Low</name><name sortKey="Petric, Martin" sort="Petric, Martin" uniqKey="Petric M" first="Martin" last="Petric">Martin Petric</name><name sortKey="Roper, Rachel L" sort="Roper, Rachel L" uniqKey="Roper R" first="Rachel L" last="Roper">Rachel L. Roper</name><name sortKey="Talbot, Pierre J" sort="Talbot, Pierre J" uniqKey="Talbot P" first="Pierre J" last="Talbot">Pierre J. Talbot</name><name sortKey="Tam, Theresa" sort="Tam, Theresa" uniqKey="Tam T" first="Theresa" last="Tam">Theresa Tam</name></noCountry><country name="Canada"><noRegion><name sortKey="Skowronski, Danuta M" sort="Skowronski, Danuta M" uniqKey="Skowronski D" first="Danuta M" last="Skowronski">Danuta M. Skowronski</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002495 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002495 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:15660517
|texte= Severe acute respiratory syndrome (SARS): a year in review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:15660517" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |